Globus Medical ROE 2010-2024 | GMED
Current and historical return on equity (ROE) values for Globus Medical (GMED) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Globus Medical ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-12-31 | $0.10B | $4.18B | 2.58% |
| 2024-09-30 | $0.09B | $4.07B | 2.31% |
| 2024-06-30 | $0.04B | $3.98B | 1.02% |
| 2024-03-31 | $0.07B | $3.92B | 1.90% |
| 2023-12-31 | $0.12B | $4.00B | 4.07% |
| 2023-09-30 | $0.16B | $4.19B | 6.36% |
| 2023-06-30 | $0.20B | $1.99B | 10.87% |
| 2023-03-31 | $0.20B | $1.92B | 11.13% |
| 2022-12-31 | $0.19B | $1.85B | 10.71% |
| 2022-09-30 | $0.16B | $1.76B | 8.87% |
| 2022-06-30 | $0.16B | $1.70B | 8.93% |
| 2022-03-31 | $0.14B | $1.79B | 8.25% |
| 2021-12-31 | $0.15B | $1.74B | 8.95% |
| 2021-09-30 | $0.19B | $1.72B | 11.64% |
| 2021-06-30 | $0.18B | $1.64B | 12.02% |
| 2021-03-31 | $0.12B | $1.56B | 8.31% |
| 2020-12-31 | $0.10B | $1.51B | 7.26% |
| 2020-09-30 | $0.10B | $1.42B | 6.89% |
| 2020-06-30 | $0.09B | $1.34B | 6.54% |
| 2020-03-31 | $0.15B | $1.36B | 10.98% |
| 2019-12-31 | $0.16B | $1.40B | 11.77% |
| 2019-09-30 | $0.15B | $1.34B | 11.56% |
| 2019-06-30 | $0.14B | $1.29B | 11.79% |
| 2019-03-31 | $0.15B | $1.24B | 12.87% |
| 2018-12-31 | $0.16B | $1.19B | 14.11% |
| 2018-09-30 | $0.14B | $1.14B | 13.61% |
| 2018-06-30 | $0.14B | $1.10B | 13.41% |
| 2018-03-31 | $0.12B | $1.03B | 12.41% |
| 2017-12-31 | $0.11B | $0.97B | 11.75% |
| 2017-09-30 | $0.11B | $0.94B | 12.20% |
| 2017-06-30 | $0.11B | $0.91B | 12.65% |
| 2017-03-31 | $0.11B | $0.87B | 12.76% |
| 2016-12-31 | $0.10B | $0.83B | 13.12% |
| 2016-09-30 | $0.12B | $0.81B | 15.46% |
| 2016-06-30 | $0.12B | $0.78B | 16.18% |
| 2016-03-31 | $0.12B | $0.75B | 16.68% |
| 2015-12-31 | $0.11B | $0.72B | 17.08% |
| 2015-09-30 | $0.10B | $0.67B | 16.38% |
| 2015-06-30 | $0.10B | $0.64B | 16.69% |
| 2015-03-31 | $0.10B | $0.61B | 17.01% |
| 2014-12-31 | $0.09B | $0.59B | 17.15% |
| 2014-09-30 | $0.09B | $0.55B | 16.73% |
| 2014-06-30 | $0.08B | $0.53B | 17.03% |
| 2014-03-31 | $0.07B | $0.50B | 14.97% |
| 2013-12-31 | $0.07B | $0.47B | 15.54% |
| 2013-09-30 | $0.07B | $0.45B | 16.34% |
| 2013-06-30 | $0.06B | $0.42B | 16.19% |
| 2013-03-31 | $0.08B | $0.41B | 20.53% |
| 2012-12-31 | $0.07B | $0.39B | 21.53% |
| 2012-09-30 | $0.07B | $0.36B | 21.10% |
| 2012-06-30 | $0.07B | $0.32B | 30.02% |
| 2012-03-31 | $0.06B | $0.30B | 42.47% |
| 2011-12-31 | $0.06B | $0.28B | 79.43% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.871B | $2.519B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $184.872B | 80.97 |
| Thermo Fisher Scientific (TMO) | United States | $161.944B | 19.59 |
| Alcon (ALC) | Switzerland | $48.146B | 32.00 |
| Edwards Lifesciences (EW) | United States | $44.378B | 29.03 |
| IDEXX Laboratories (IDXX) | United States | $35.062B | 40.55 |
| DexCom (DXCM) | United States | $27.989B | 43.26 |
| IQVIA Holdings (IQV) | United States | $27.341B | 15.13 |
| Mettler-Toledo (MTD) | United States | $22.312B | 26.01 |
| STERIS (STE) | Ireland | $22.081B | 25.25 |
| Waters (WAT) | United States | $20.688B | 29.30 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.273B | 0.00 |
| Hologic (HOLX) | United States | $13.059B | 14.09 |
| Sysmex ADR (SSMXY) | Japan | $11.620B | 0.00 |
| Penumbra (PEN) | United States | $11.341B | 89.01 |
| Masimo (MASI) | United States | $8.698B | 36.50 |
| Teleflex (TFX) | United States | $6.355B | 9.78 |
| Glaukos (GKOS) | United States | $5.380B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.407B | 23.09 |
| TransMedics (TMDX) | United States | $3.112B | 91.10 |
| PROCEPT BioRobotics (PRCT) | United States | $2.986B | 0.00 |
| Veracyte (VCYT) | United States | $2.389B | 42.96 |
| LivaNova (LIVN) | United Kingdom | $2.011B | 12.21 |
| Nihon Kohden (NHNKY) | Japan | $1.969B | 10.77 |
| Elekta AB (EKTAY) | Sweden | $1.945B | 17.48 |
| Alphatec Holdings (ATEC) | United States | $1.604B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.266B | 6.40 |
| Pulse Biosciences (PLSE) | United States | $1.145B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.122B | 0.00 |
| Artivion (AORT) | United States | $1.011B | 94.76 |
| OPKO Health (OPK) | United States | $0.927B | 0.00 |
| AxoGen (AXGN) | United States | $0.721B | 0.00 |
| IRadimed (IRMD) | United States | $0.666B | 34.94 |
| Mesa Laboratories (MLAB) | United States | $0.626B | 13.69 |
| RxSight (RXST) | United States | $0.598B | 0.00 |
| SiBone (SIBN) | United States | $0.581B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.577B | 9.30 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.543B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.506B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.479B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.445B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.403B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.403B | 0.00 |
| NeuroPace (NPCE) | United States | $0.383B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.377B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.334B | 17.87 |
| Pacific Biosciences Of California (PACB) | United States | $0.333B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.310B | 6.58 |
| Neuronetics (STIM) | United States | $0.288B | 0.00 |
| 908 Devices (MASS) | United States | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| CVRx (CVRX) | United States | $0.191B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.180B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.179B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.165B | 0.00 |
| Accuray (ARAY) | United States | $0.159B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.158B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.132B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.116B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.108B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.100B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.086B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.079B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 10.75 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.055B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.038B | 0.00 | |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.20 |